Health
Start-up awarded grant to develop contrast agent for early detection of liver disease – EurekAlert
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
ATLANTA–Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
“We have been working on this breakthrough in the lab for several years,” said Yang. “This funding will help us to…
-
General22 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News13 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General13 hours agoHackers release Qantas customers’ data on dark web
-
General23 hours agoHotel owner mocks Wollongong Council’s palm tree art after renovation refusal